An Evidence-Based Approach To Managing Acute Otitis Media
TOC Will Appear Here

An Evidence-Based Approach To Managing Acute Otitis Media

Below is a free preview. Log in or subscribe for full access. Or, get a free sample article ED Assessment and Management of Pediatric Acute Mild Traumatic Brain Injury and Concussion:
Please provide a valid email address.
Table of Contents
Table of Contents
  1. Abstract
  2. Case Presentation
  3. Introduction
  4. Critical Appraisal Of The Literature
  5. Etiology And Pathophysiology
  6. Differential Diagnosis
  7. Prehospital Care
  8. Emergency Department Evaluation
    1. History
      1. Clinical Practice Pearl
    2. Physical Examination: Basic Principles
      1. Otoscopic Findings
      2. What's New In The 2013 AAP Guidelines
  9. Diagnostic Studies
  10. Treatment
    1. Antibiotics Versus Placebo
      1. Antibiotics Versus Placebo: The Bottom Line
    2. Initial Antibiotics Versus A Watchful-Waiting Approach
    3. Initial Choice Of Antibiotic
      1. What's New In The 2013 Guidelines
    4. Duration Of Therapy
    5. Antibiotic Dosing
    6. Persistent Acute Otitis Media
    7. Pain Control
      1. Acetaminophen And Ibuprofen
      2. Topical Agents (Antipyrine Solution, Lignocaine, Naturopathic Solution)
      3. Narcotic Analgesics
      4. Other Remedies
      5. Pain Control: The Bottom Line
    8. Decongestants And Antihistamines
    9. Effect Of Age On Treatment
      1. What's New In The 2013 AAP Guidelines
    10. Adverse Events Of Treatment
    11. Complications Of Acute Otitis Media
      1. Mastoiditis
      2. Meningitis
      3. Complications Of Acute Otitis Media: The Bottom Line
    12. Treatment Summary And 2013 American Academy Of Pediatrics Guidelines
  11. Special Circumstances
    1. Patients To Exclude From The Watchful-Waiting Approach
    2. Patients With Bilateral Acute Otitis Media Or Otorrhea
    3. Patients Who Cannot Tolerate Oral Antibiotics
    4. Patients With Penicillin Allergies
    5. Patients With Chronic Suppurative Otitis Media Or Acute Otitis Media Through Tympanostomy Tubes
      1. Patients With Acute Otitis Media Through Tympanostomy Tubes Or Chronic Suppurative Otitis Media: The Bottom Line
  12. Controversies And Cutting Edge
  13. Disposition
  14. Summary
  15. Risk Management Pitfalls For Acute Otitis Media In Children
  16. Time- And Cost-Effective Strategies
  17. Case Conclusions
  18. Clinical Pathway For Suspected Acute Otitis Media In Pediatric Patients
  19. Tables and Figures
    1. Table 1. Differential Diagnosis Of Ear Pain
    2. Table 2. Definitions Of Acute Otitis Media And Otitis Media With Effusion
    3. Figure 1. 2013 American Academy Of Pediatrics Guidelines For Acute Otitis Media
  20. References


Acute otitis media is one of the most common pediatric illnesses; however, there is considerable controversy in its management. While most cases are treated with antibiotics, there is a growing concern regarding antibiotic overuse and subsequent drug resistance. Researchers in the Netherlands have developed a “watchful waiting" (ie, an observation approach) that has been successful in treating acute otitis media, although it has not gained widespread popularity in the United States. This review will summarize the latest research on diagnosing acute otitis media as well as different treatment regimens, including the efficacy of the watchful-waiting approach.

Key words: acute otitis media, AOM, otitis media with effusion, watchful-waiting, observation, wait-and-see, ear pain, otalgia, otorrhea, bulging tympanic membrane, AAP guidelines

Case Presentation

A mother has brought her 2 children to the ED on a Saturday evening, with both complaining of ear pain. The first child, a 3-year-old girl, has been complaining of a right-sided earache for the past 2 days. Today, she had a fever of 38.4°C at home. She has been fussier than usual, but she is still active and has been eating normally. She is an otherwise healthy girl and has never been diagnosed with acute otitis media before. On otoscopic exam, the right tympanic membrane is erythematous and bulging, with decreased movement on insufflation.

The second child, the 2-year-old brother of the first patient, has been tugging on his left ear for the past day. Otherwise, he seems fine, although he has a runny nose and has sneezed several times. He has not had a fever and has no medical problems. Although he does not appear to be as sick as his sister, his mother wonders if he has caught the same bug. On his otoscopic exam, there is opacity of the tympanic membranes bilaterally, with retraction and decreased movement of the tympanic membrane with insufflation on the left.

The mother asks you if her children will need antibiotics for an infection. Both children attend daycare, and the mother is worried because other children there have had ear infections. You think:

  • Do these patients have risk factors for acute otitis media?
  • Is either history suggestive of a particular diagnosis?
  • Is either patient’s physical examination consistent with acute otitis media?
  • Are other diagnostic tests necessary?
  • Should I give either of these patients a prescription for antibiotics? If so, which antibiotic should I give, and for how long a duration?
  • What pain medications are appropriate for these patients?
  • What complications should I be worried about?
  • Can I discharge these patients safely? What precautions should I give the parents?


Acute otitis media (AOM) is one of the most common infections diagnosed in children in the United States. It accounts for 13% of all emergency department (ED) visits and 30 million clinic visits by children, making it the second leading diagnosis in pediatric ED visits (after upper respiratory infection).1 In 2000, $5 billion was spent on the diagnosis and treatment of AOM.2 Traditional management of AOM – particularly in patients diagnosed in the ED – has included antibiotic therapy. Although a 2002 study found a decrease in the overall populationbased antibiotic prescription rate for AOM,3 a 2007 study reported that up to 91% of ED patients received antibiotic prescriptions for AOM.4 Traditional antibiotic treatment for AOM has been called into question in the past several decades based on early studies that suggested a benign natural history of the disease. A meta-analysis of clinical trials from 1966 to 1992 showed that AOM spontaneously resolved without treatment in 80% of cases, and it concluded that antibiotic prescriptions may not be necessary for all patients.5 Although the results of these studies were later called into question based on their less-than-stringent diagnostic criteria for AOM, researchers began to turn to other models for treating AOM.

For more than 20 years, physicians in the Netherlands have been treating AOM in children with initial observation or a “watchful-waiting” approach. Initial studies demonstrated that this approach was safe, effective, and acceptable to parents. 6,7 As a result of this new treatment paradigm, a national survey of Dutch general physicians found that antibiotics for children with AOM were given in 14% to 20% of diagnosed cases from 1987 to 2001;8 however, more-recent data indicate that antibiotic prescription rates for AOM are increasing in the Netherlands. In 2003, 1 study reported prescription rates of up to 64%,9 and another study reported prescription rates of 40% to 50% from 2002 to 200810 (although these numbers are still lower than their United States counterparts). Although the healthcare system in the Netherlands differs greatly from that in the United States in that many of these patients are treated by their family physicians with close follow-up, researchers began to study this treatment model in the hope that the Dutch system would be applicable to United States physicians and their patients.

The interest in a new treatment model for AOM in the United States was also fueled by the growing rate of antibiotic use and the subsequent concern for antibiotic resistance. Early studies found that, as antibiotic overuse increases, the resistance to penicillin of the Streptococcus pneumoniae bacterium has been increasing (27.5% of strains in 1995 were resistant compared to 43.8% in 1997).11 By comparison, in the Netherlands, resistance rates of S pneumoniae strains to penicillin are very low (as low as < 1%, as reported in a small study involving respiratory isolates in 89 patients).12 With the 2010 introduction of the new pneumococcal conjugate vaccine (PCV13), the microbiology of AOM continues to change, but antibiotic resistance remains a concern.13

In an effort to decrease antibiotic prescribing and antibiotic resistance trends, and building on the successes of the watchful-waiting approach in the Netherlands, the American Academy of Family Physicians (AAFP) and the American Academy of Pediatrics (AAP) released a practice guideline in 2004 that suggested observation without antibiotics in certain cases of AOM.7 Although the 2004 guideline recommendations received significant publicity, adherence to them was not widespread, and data show that there was little difference in antibiotic prescribing rates for AOM after publication.14,15

Since 2004, researchers have begun to scrutinize closely the clinical trials from the past several decades. Many older trials have been criticized because they utilized broad inclusion criteria, leading to inaccurate diagnosis on study entry and creating a study population not reflective of the true AOM population. Many studies included children who did not have AOM, children who often had otitis media with effusion (OME), or children who had no middle ear disease at all. They also excluded very young children, children with severe disease, children with recent antibiotic treatment, and children with recent AOM.16 Newer trials have subsequently included a very strict definition of AOM, prompting the AAP to revise their guidelines in 2013.17 These guidelines continue to recommend an observation approach, but they strongly emphasize appropriate diagnostic criteria. The literature will continue to evolve as better-designed clinical trials are conducted using these criteria. This issue of Pediatric Emergency Medicine Practice will present evidence-based recommendations for the diagnosis of AOM and will review the efficacy of different treatment modalities.

Critical Appraisal Of The Literature

A literature search was performed using the PubMed and Ovid MEDLINE® databases. Searches were limited to studies in English involving human subjects. Studies were limited to clinical trials, meta-analyses, practice guidelines, randomized controlled trials (RCTs), review articles, and systematic reviews. Prospective and retrospective cohort studies were used for the epidemiology section. Search terms included: acute otitis media, children, treatment, and emergency department. This search yielded 1208 studies; however, articles related to prevention or prophylaxis of AOM, chronic otitis media (OM), myringotomy/tympanostomy tubes, or upper respiratory infections (in general) were not reviewed. The Cochrane Database of Systematic Reviews was searched for reviews using the same terms as above,7 and relevant reviews were identified. The Database of Abstracts of Reviews of Effectiveness (DARE) was searched using the terms as above and identified 8 relevant reviews. Additionally, the National Guideline Clearinghouse ( was explored, and 1 guideline was found.

In 2004, the AAP and the AAFP partnered with the Agency for Healthcare Research and Quality (AHRQ) and the Southern California Evidence-Based Practice Center to develop a set of clinical practice guidelines for the management of AOM.7 These guidelines were based largely on data gathered for the 2001 evidence report of AOM management published by the AHRQ.18 The issues addressed in the AAP/AAFP guidelines were: (1) the definition of AOM; (2) the natural history of AOM without antibacterial treatment; (3) the effectiveness of antibacterial agents in preventing clinical failure; and (4) the relative effectiveness of specific antibacterial regimens. Their search of the literature from 1966 to 1999 uncovered 3461 articles, and 74 studies were reviewed in full. The published clinical practice guidelines were systematic, evidence based, and peer reviewed. Subsequent to the 2004 publication of the guidelines, the AHRQ issued a 2010 update to their 2001 evidence report.19 This resource was also extensively reviewed and provided a critical analysis of the latest research addressing the following: (1) the clinical symptoms and otoscopic findings to diagnose AOM; (2) the impact of the pneumococcal heptavalent immunization (PCV7) on AOM microbial epidemiology; (3) the comparative effectiveness of different treatment options for treating uncomplicated AOM in average-risk children; (4) the comparative effectiveness of different management options for recurrent OM and persistent OM or relapse of AOM; (5) the treatment outcomes based on the following characteristics: laterality, otorrhea or perforation, severity, comorbidities, age groups, race, ethnicity, or daycare attendance; and (6) adverse effects of treatment.

In 2013, the AAP again partnered with the AHRQ and the Southern California Evidence-Based Practice Center to publish an update of the 2004 guidelines.17 The 2013 guidelines address appropriate diagnosis of AOM using a strict definition, pain management, initial observation versus antibiotic treatment, appropriate choices of antibiotics, and preventative measures. These guidelines are based largely on the 2010 AHRQ update as well as continued review of newly published literature. This source represents the most current review of the literature on AOM.

Overall, the diagnosis and treatment of AOM has been a well-studied topic. There are many large RCTs, meta-analyses, and systematic reviews addressing the management of AOM. Differences in study design (particularly diagnostic criteria for inclusion or exclusion of subjects and definitions of clinical success or failure) have made it difficult to compare different studies. The biggest flaw in the AOM literature is the lack of a strict definition of AOM for study participants. Many studies (particularly older studies prior to 2000) included subjects that did not have AOM by the current definition but had either OME or a normal variant. It is difficult to draw conclusions from these studies because a true population of AOM was not studied; however, recent studies have applied strict inclusion criteria to study participants, and this topic has been extensively discussed in the 2013 AAP guidelines as well as throughout this article.

Risk Management Pitfalls For Acute Otitis Media In Children

  1. “I gave the patient a script for antibiotics, so he didn't need pain medication.” Always treat a patient’s pain, regardless of the choice to give antibiotics. Ibuprofen and/or acetaminophen are first-line therapies, but topical analgesics may be used as well. Narcotics should be reserved for children with severe otalgia resistant to first-line therapies.
  2. “The child had a red TM on otoscopic examination, so I treated him for AOM.” Erythema of the TM alone is not specific for AOM. The TM can be red for other reasons, including crying, high fever, and manipulation of the ear canal (such as from cerumen removal). A slightly red TM alone is not predictive of AOM, while a distinctly red or hemorrhagic TM is slightly suggestive. The diagnosis of AOM correlates most with mobility and position (a bulging, immobile TM). The 2013 AAP guidelines require a bulging TM and evidence of middle ear effusion on pneumatic otoscopy for diagnosis of AOM.
  3. “It was difficult to perform an otoscopic examination on this child, so to be safe, I skipped it and diagnosed him with AOM and treated him with antibiotics.” Clinicians should make their best effort to perform an adequate otoscopic examination in children to spare them from unnecessary antibiotics. The child should be calmed and placed in the caregiver’s lap for examination. Cerumen should be removed if it obstructs the view of the TM (this can be achieved with docusate sodium and irrigation or by manual extraction). The emergency clinician should perform pneumatic otoscopy on all patients to confirm the presence of a middle ear effusion. Certain patients with a definitive diagnosis of AOM may not require antibiotics.
  4. “This patient had ongoing ear pain for morethan 1 week and signs of middle ear effusion on otoscopic examination but no TM bulging. I treated her with antibiotics.” There is no evidence that antibiotics are beneficial for OME. OME, by definition, is not an acute process. AOM requires moderate to severe bulging of the TM or acute onset of symptoms ( < 48 h) plus mild TM bulging or intense erythema of the TM for diagnosis.
  5. “This patient returned to the ED with persistent middle ear effusion after an episode of AOM. This represented a failure of treatment, so I prescribed a stronger antibiotic.” Persistent middle ear effusion is very common after an episode of AOM, but it should resolve after 3 months. Patients with persistent effusions should be referred to their pediatrician, as they may need further testing to assess for hearing loss or cognitive delays. There is no need to change their antibiotic regimen.
  6. “I was worried that this patient with AOM would develop a serious complication such as mastoiditis or meningitis if I didn't treat him with antibiotics.” There is no evidence that delayed or withdrawn antibiotics are associated with mastoiditis or meningitis, which are extremely rare complications of AOM. Some studies have shown an association between mastoiditis and recent antibiotic use. Do not prescribe antibiotics solely to avoid these complications.
  7. “My patient had a history of recurrent AOM and presented to the ED today with ear pain and findings of AOM on otoscopy. He had no fever and looked well, so I treated him with the watchful-waiting approach.” History of recurrent AOM was considered a contraindication to observation in the 2004 AAP/AAFP guidelines. The 2013 guidelines do not specifically list recurrent AOM as a contraindication to observation; however, management of these patients can be difficult. Emergency clinicians should consider consulting a specialist or discussing the case with the child’s pediatrician before initiating treatment. Some patients with recurrent AOM may benefit from tympanocentesis to isolate the causative middle ear pathogen, a procedure rarely performed in the ED. The 2013 AAP guidelines recommend amoxicillin-clavulanate (or an alternative antibiotic with beta-lactamase coverage) for patients with a history of recurrent AOM unresponsive to amoxicillin.
  8. “These parents seem pretty aggressive. They won’t be happy if I don’t treat their child with antibiotics. Even if I give them a script to hold and instruct them to fill it in 48 to 72 hours if the child does not improve, they’ll probably just go straight to the pharmacy from the ED to fill it.” Recent studies have shown that parents are satisfied with a watchful-waiting approach as long as the child’s pain is addressed. Around 80% of parents did not fill their prescription. It is important for emergency clinicians to explain their instructions clearly, provide reassurance, and treat pain. Note that if the child has had multiple previous episodes of AOM that were treated with antibiotics, the parents are more likely to fill the prescription than if this is the child’s first episode.
  9. “This child had AOM. I got a complete blood count to see how high his white count was and a culture of his ear drainage to see what the inciting pathogen was.”Routine complete blood counts are not recommended in nonsevere AOM as they do not contribute to management. In an immunocompromised patient, they may be helpful. Routine culture and gram stain of middle ear fluid is not recommended, although it may help guide treatment in patients with persistent AOM or chronic AOM.
  10. “This child had AOM. Antibiotics are very safe drugs, so I didn't have to worry about adverse reactions from treatment.” While antibiotics are some of the safer drugs on the market, they are not without side effects. Diarrhea, vomiting, and rash are commonly seen in children prescribed antibiotics for AOM and the risk is greater for children who receive broad-spectrum antibiotics such as moxicillinclavulanate. Parents should be educated about possible side effects when children need to be treated with antibiotics.

Tables and Figures

Table 1. Differential Diagnosis Of Ear Pain

Table 2. Definitions Of Acute Otitis Media And Otitis Media With Effusion


Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.

To help the reader judge the strength of each reference, pertinent information about the study, such as the type of study and the number of patients in the study will be included in bold type following the references, where available. The most informative references cited in this paper, as determined by the author, will be noted by an asterisk (*) next to the number of the reference.

  1. Pitts SR, Niska RW, Xu J, et al. National hospital ambulatory medical care survey: 2006 emergency department summary. Natl Health Stat Report. 2008;7:1-38. (Retrospective epidemiological study)
  2. Bondy J, Berman S, Glazner J, et al. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000;105(6):E72. (Economic analysis; 87,057 patients)
  3. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23):3096-3102. (Retrospective epidemiological study; 6500-13,600 pediatric visits)
  4. Fischer T, Singer AJ, et al. National trends in emergency department antibiotic prescribing for children with acute otitis media, 1996–2005. Acad Emerg Med. 2007;14(12):1172-1175. (Retrospective epidemiological study)
  5. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from 33 randomized trials. J Pediatr. 1994;124(3):355-367. (Meta-analysis; 5400 patients)
  6. van Buchem FL, Peeters MF, van Hof MA. Acute otitis media: a new treatment strategy. Br Med J (Clin Res Ed).1985;290(6474):1033-1037. (Retrospective case study; 4860 patients)
  7. * Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451-1465. (Practice guideline)
  8. Otters HB, van der Wouden JC, Schellevis FG, et al. Trends in prescribing antibiotics for children in Dutch general practice. J Antimicrob Chemother. 2004;53(2):361-366. (Cross-sectional survey; 86,577 patients from 1987 and 76,010 patients from 2001)
  9. Plasschaert AI, Rovers MM, Schilder AG, et al. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics. 2006;117(6):1879-1886. (Retrospective cohort study; approximately 60,000 patients)
  10. Uijen HJ, Bindels PJ, Schellevis FG, et al. ENT problems in Dutch children: trends in incidence rates, antibiotic prescribing, and referrals 2002-2008. Scand J Prim Health Care. 2011;29(2):75-79. (Retrospective epidemiological study)
  11. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27(4):764-770. (Multicenter laboratory molecular epidemiology study; 1047 total respiratory isolates; 845 isolates from United States laboratories; 202 isolates from Canadian laboratories)
  12. Hermans PW, Sluijter M, Elzenaar K, et al. Penicillinresistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis. 1997;175(6):1413-1422. (Retrospective laboratory molecular epidemiology survey; 89 respiratory isolates)
  13. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304-309. (Prospective study; 200 patients)
  14. Vernacchio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/ American Academy of Family Physicians clinical practice guideline. Pediatrics. 2007;120(2):281-287. (Mail survey of 299 primary care physicians)
  15. Coco A, Vernacchio L, Horst M, et al. Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics. 2010;125(2):214-220. (Retrospective epidemiology survey; 1114 physicians)
  16. Pichichero ME, Casey JR. Diagnostic inaccuracy and subject exclusions render placebo and observational studies of acute otitis media inconclusive. Pediatr Infect Dis J. 2008;27(11):958- 962. (Review of 12 observational studies and 13 natural history studies)
  17. * Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-e999. (Practice guideline)
  18. * Marcy M, Takata G, Chan LS, et al. Management of acute otitis media. Evidence Report/Technology Assessment No. 15. AHRQ Publication No. 01-E010. Rockville, MD: Agency for Healthcare Research and Quality; 2001. (Evidence-based review)
  19. * Shekelle PG, Takata G, Newberry SJ, et al. Management of acute otitis media: update. Evidence Report/Technology Assessment No. 198. AHRQ Publication No. 11-E004 Rockville, MD: Agency for Healthcare Research and Quality; 2010. (Systematic review)
  20. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83- 94. (Prospective cohort study; 877 patients)
  21. Ladomenou F, Kafatos A, Tselentis Y, et al. Predisposing factors for acute otitis media in infancy. J Infect. 2010;61(1):49-53. (Prospective study; 1049 mother-infant pairs)
  22. Kalu SU, Ataya RS, McCormick DP, et al. Clinical spectrum of acute otitis media complicating upper respiratory tract viral infection. Pediatr Infect Dis J. 2011;30(2):95-99. (Prospective study; 213 patients)
  23. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815-823. (Prospective cohort study; 294 patients)
  24. Alper CM, Winther B, Mandel EM, et al. Rate of concurrent otitis media in upper respiratory tract infections with specific viruses. Arch Otolaryngol Head Neck Surg. 2009;135(1):17-21. (Prospective study; 176 patients)
  25. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340(4):260-264. (Prospective study; 456 patients)
  26. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalence of bacteria and viruses. Clin Infect Dis. 2006;43(11):1417-1422. (Prospective study; 79 patients)
  27. Chonmaitree T, Ruohola A, Hendley JO. Presence of viral nucleic acids in the middle ear: acute otitis media pathogen or bystander? Pediatr Infect Dis J. 2012;31(4):325-330. (Review article)
  28. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403-409. (Randomized double-blind trial; 1662 patients)
  29. Grijalva CG, Poehling KA, Nuorti JP. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118(3):865-873. (Retrospective epidemiological study)
  30. Zhou F, Shefer A, Kong Y, et al. Trends in acute otitis mediarelated health care utilization by privately insured children in the United States, 1997-2004. Pediatrics. 2008;121(2):253- 260. (Retrospective population analysis)
  31. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23(9):824-828. (Prospective observational cohort study; 551 patients)
  32. Block SL, Hedrick J, Harrison CJ et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23(9):829-833. (Prospective observational cohort study; 379 patients)
  33. Pichichero MC, Casey JR, Center K, et al. Efficacy of PCV13 in prevention of AOM and NP colonization in children. First year of data from the US. Presented at the 8th international symposium on pneumococci and pneumococcal diseases, March 11-15, 2012. Iguaçu Falls, Brazil. 2012. (Prospective study: 118 patients)
  34. Pichichero et al. Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J. 2013; Ahead of print. (Prospective study; 254 patients)
  35. Tos M. Epidemiology and natural history of secretory otitis. Am J Otol. 1984;5(6):459-462. (Prospective cohort study; 801 patients)
  36. Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J. 1998;17(12):1105-1113.
  37. American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion. Otitis media with effusion. Pediatrics. 2004;113(5):1412-1429. (Clinical practice guideline)
  38. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003;113(10):1645-1657. (Systematic literature review and meta-analysis)
  39. Teele DW, Klein JO, Chase C, et al. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group. J Infect Dis. 1990;162(3):685. (Prospective study; 207 patients)
  40. Schwartz RH, Rodriguez WJ, Brook I, et al. The febrile response in acute otitis media. JAMA. 1981;245(20):2057-2058. (Prospective study; 671 patients)
  41. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA. 2003;290(12):1633-1640. (Systematic review)
  42. Niemela M, Uhari M, Jounio-Ervasti K, et al. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J. 1994;13(9):765-768. (Prospective survey; 354 patients)
  43. Laine MK, Tahtinen PA, Ruuskanen O, et al. Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics. 2010;125(5):1154-1161. (Prospective study; 469 patients)
  44. Kontiokari T, Koivunen P, Niemela M, et al. Symptoms of acute otitis media. Pediatr Infect Dis J. 1998;17(8):676-679. (Prospective study; 857 patients)
  45. Davis HW, Parker K. Otoscopic examination. King C, Henretig FM, eds. In: Textbook of Pediatric Emergency Procedures. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008. (Textbook chapter)
  46. Kaleida, PH. The COMPLETES exam for otitis. Contemp Pediatr. 1997;14:93-101. (Review article)
  47. Bluestone CD, Klein JO. Methods of examination: clinical examination. Bluestone CD, Stool SE, eds. In: Pediatric Otolaryngology. 2nd ed. Philadelphia, PA: WB Saunders, Inc; 1990. (Textbook chapter)
  48. Pelton SI. Otoscopy for the diagnosis of otitis media. Pediatr Infect Dis J. 1998;17(6):540-543. (Review article)
  49. Karma PH, Penttila MA, Sipila MA, et al. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media: the value to different otoscopic findings. Int J Pediatr Otorhinolaryngol. 1989;17(1):37-49. (Prospective study; 2911 patients)
  50. Wilson SA, Lopez R. Clinical inquiries. What is the best treatment for impacted cerumen? J Fam Pract. 2002;51(2):117. (Review article)
  51. Riviello RJ, Brown NA. Otolaryngologic procedures. Roberts JR and Hedges JR, eds. In: Clinical Procedures in Emergency Medicine. 5th ed. Philadelphia, PA: Saunders; 2010. (Textbook chapter)
  52. Shaikh N, Hoberman A, Rockette HE, et al. Development of an algorithm for the diagnosis of otitis media. Acad Pediatr. 2012;12(3):214-218. (Prospective study; 263 patients)
  53. Stool SE, Berg AO, Berman S, et al. Otitis media with effusion in young children. Clinical Practice Guideline, Number 12. AHCPR Publication No. 94-0622. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services; 1994. (Clinical practice guideline)
  54. Shekelle P, Takata G, Chan LS, et al. Diagnosis, natural history, and late effects of otitis media with effusion. Evidence Report/Technology Assessment No. 55. AHRQ Publication No. 03-E023. Rockville, MD: Agency for Healthcare Research and Quality; 2003. (Review article)
  55. Shaikh N, Hoberman A, Kaleida PH, et al. Otoscopic signs of otitis media. Pediatr Infect Dis J. 2011;30(10):822-826. (Prospective study; 783 patients)
  56. Laine MK, Tahtinen PA, Helenius KK, et al. Acoustic reflectometry in discrimination of otoscopic diagnoses in young ambulatory children. Pediatr Infect Dis J. 2012;31(10):1007- 1011. (Prospective study; 515 patients)
  57. Helenius KK, Laine MK, Tahtinen PA, et al. Tympanometry in discrimination of otoscopic diagnoses in young ambulatory children. Pediatr Infect Dis J. 2012;31(10):1003-1006. (Prospective study; 515 patients)
  58. Halsted C, Lepow ML, Balassanian N, et al. Otitis media: microbiology and evaluation of therapy. Ann N Y Acad Sci. 1967;145(2):372-378. (Randomized controlled trial; 106 patients)
  59. Laxdal OE, Merida J, Jones RH. Treatment of acute otitis media: a controlled study of 142 children. Can Med Assoc J. 1970;102(3):263-268. (Randomized controlled trial; 142 patients)
  60. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate - triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr. 1972;11(4):205-214. (Randomized controlled trial; 280 patients)
  61. Burke P, Bain J, Robinson D, et al. Acute red ear in children: controlled trial of nonantibiotic treatment in general practice. BMJ. 1991;303(6802):558-562. (Randomized, controlled trial; 232 patients)
  62. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87(4):466-474. (Randomized controlled trial; 536 patients)
  63. Damoiseaux RA, van Balen FA, Hoes AW, et al. Primary care-based randomised, double-blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ. 2000;320(7231):350-354. (Randomized doubleblind controlled trial; 240 patients)
  64. Le Saux N, Gaboury I, Baird M, et al. A randomized, doubleblind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ. 2005;172(3):335-341. (Randomized double-blind controlled trial; 512 patients)
  65. Glasziou PP, Hayem M, Del Mar CB. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2000;2:CD000219. (Meta-analysis; 1962 patients)
  66. Tahtinen PA, Laine MK, Huovinen P. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116-126. (Randomized controlled trial; 319 patients)
  67. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105-115. (Randomized controlled trial; 291 patients)
  68. Appelman CL, Van Balen FA, Van de Lisdonk EH, et al. Otitis media acuta. NHG-standaard (eerste herziening) [in Dutch]. Huisarts Wet. 1999;42:362-366. (Practice guideline)
  69. Swedish Medical Research Council. Treatment for acute inflammation of the middle ear: consensus statement. Stockholm, Sweden: Swedish Medical Research Council; 2000. Available at: Konsensut_ora_eng.pdf. Accessed March 2, 2013. (Practice guideline)
  70. Siegel RM, Kiely M, Bien JP, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics. 2003;112(3):527-531. (Prospective study; 194 patients)
  71. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005;115(6):1455-1465. (Randomized controlled trial; 223 patients)
  72. Spiro DM, Tay KY, Arnold DH, et al. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial JAMA. 2006;296(10):1235-1241. (Randomized controlled trial; 283 patients)
  73. Fischer T, Singer AJ, Chale A. Observation option for acute otitis media in the emergency department. Pediatr Emer Care. 2009;25(9):575-578. (Prospective case series; 144 patients)
  74. Tahtinen PA, Laine MK, Ruuskanen O, et al. Delayed versus immediate antimicrobial treatment for acute otitis media. Pediatr Infect Dis J. 2012;31(12):1227-1232. (Prospective study; 214 patients)
  75. Chao JH, Kunkov S, Reyes LB, et al. Comparison of two approaches to observation therapy for acute otitis media in the emergency department. Pediatrics. 2008;121(5):1352-1356. (Prospective study; 232 patients)
  76. Marchisio P, Mira E, Klersy C, et al. Medical education and attitudes about acute otitis media guidelines: a survey of Italian pediatricians and otolaryngologists. Pediatr Infect Dis J. 2009;28(1):144. (Cross-sectional survey; 2012 pediatricians and otolaryngologists)
  77. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772-1778. (Prospective cohort study; 212 patients)
  78. Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63(3):511-519. (In vitro analysis of 143 nontypeable H influenzae respiratory isolates, 208 S pneumoniae isolates, and 62 M catarrhalis isolates)
  79. Varsano I, Frydman M, Amir J, et al. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. A double-blind clinical trial. Chemotherapy. 1988;34(1):39-46. (Randomized doubleblind controlled trial; 52 patients)
  80. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics. 1993;91(1):23-30. (Randomized double-blind controlled trial; 233 patients)
  81. Kara CO, Ozuer MZ, Kilic I, et al. Comparison of amoxicillin with second- and third-generation cephalosporins in the treatment of acute otitis media. Infez Med. 1998;6(2):93-95. (Randomized controlled trial; 75 patients)
  82. Zhang YM, Dong P, Lu P. [Efficacy and safety of one-dose ceftriaxone vs. ten-day oral amoxicillin for treatment of acute otitis media in children]. Zhonghua Er Ke Za Zhi. 2003;41(2):135-138.[article in Chinese] (Randomized comparative multicenter trial; 236 patients)
  83. Bauchner H, Adams W, Barnet E, et al. Therapy for acute otitis media. Preference of parents for oral or parenteral antibiotic. Arch Pediatr Adolesc Med. 1996;150(4):396-369. (Randomized controlled trial; 648 patients)
  84. Cohen R, Navel M, Grunberg J, et al. One-dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18(5):403-409. (Randomized comparative multicenter trial; 513 patients)
  85. Wang CY, Lu CY, Hsieh YC, et al. Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children. J Microbiol Immunol Infect. 2004;37(1):57-62. (Randomized comparative trial; 73 patients)
  86. Biner B, Celtik C, Oner N, et al. The comparison of singledose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/ clavulanate for the treatment of children with acute otitis media. Turk J Pediatr. 2007;49(4):390-396. (Randomized comparative trial; 104 patients)
  87. Varsano I, Volovitz B, Horev Z, et al. Intramuscular ceftriaxone compared with oral amoxicillin-clavulanate for treatment of acute otitis media in children. Eur J Pediatr. 1997;156(11):858-863. (Randomized comparative trial; 215 patients)
  88. Pestalozza G, Cioce C, Facchini M. Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media. Scand J Infect Dis Suppl. 1992;83:22-25. (Randomized comparative trial; 30 patients)
  89. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother. 1993;31(Suppl E):65-71. (Randomized comparative trial; 159 patients)
  90. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother. 1993;31(Suppl E):81-88. (Randomized comparative multicenter trial; 389 patients)
  91. Principi N. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. Eur J Clin Microbiol Infect Dis. 1995;14(8):669-676. (Randomized comparative multicenter trial; 484 patients)
  92. Arguedas A, Loaiza C, Herrera M, et al. Comparative trial of 3-day azithromycin versus 10-day amoxycillin/clavulanate potassium in the treatment of children with acute otitis media with effusion. Int J Antimicrob Agents. 1996;6(4):233-238. (Randomized comparative trial; 92 patients)
  93. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19(2):95-104. (Randomized comparative single-blind trial; 238 patients)
  94. Dunne MW, Latiolais T, Lewis B, et al. Randomized, doubleblind study of the clinical efficacy of 3 days of azithromycin compared with coamoxiclav for the treatment of acute otitis media. J Antimicrob Chemother. 2003;52(3):469-472. (Randomized comparative trial; 373 patients)
  95. Guven M, Bulut Y, Sezer T, et al. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin. Int J Pediatr Otorhinolaryngol. 2006;70(5):915-923. (Randomized comparative single-blind trial; 180 patients)
  96. Rodriguez AF. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media. J Antimicrob Chemother. 1996;37(Suppl C):63-69. (Randomized comparative trial; 234 patients)
  97. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44(1):43-50. (Randomized comparative trial; 138 patients)
  98. Oguz F, Unuvar E, Suoglu Y, et al. Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. 3 days azithromycin. Int J Pediatr Otorhinolaryngol. 2003;67(1):43-51. (Randomized comparative single-blind trial; 78 patients)
  99. Kozyrskyj AL, Klassen TP, Moffatt M, et al. Short-course antibiotics for acute otitis media. Cochrane Database Syst Rev. 2010;9:CD001095. (Systematic review; 12,045 patients)
  100. Casey JR, Block SL, Hedrick J, et al. Comparison of amoxicillin/ clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs. 2012;72(15):1991-1997. (Randomized controlled investigator-blind trial; 330 patients)
  101. Scottish Intercollegiate Guideline Network. Diagnosis and management of childhood otitis media in primary care. Edinburgh, Scotland: Scottish Intercollegiate Guideline Network; 2003. Available at: fulltext/66/index.html. Accessed March 2, 2013.
  102. Kozyrskyj AL, Hildes-Ripstein GE, Longstaffe SE, et al. Short-course antibiotics for acute otitis media. Cochrane Database Syst Rev. 2000;2:CD001095. (Systematic review; 1524 patients)
  103. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis, and tonsillopharyngitis. Pediatr Infect Dis J. 1997;16(7):680-695. (Systematic review)
  104. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J. 1997;16(7):710- 711. (Prospective study; 20 patients)
  105. Carlin SA, Marchant CD, Shurin PA, et al. Host factors and early therapeutic response in acute otitis media. J Pediatr. 1991;118(2):178-183. (Retrospective study; 293 patients)
  106. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20(9):829-837. (Prospective study; 521 patients)
  107. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16(5):463-470. (Randomized controlled trial; 868 patients)
  108. Pichichero ME, Reed MD. Variations in amoxicillin pharmacokinetic/ pharmacodynamic parameters may explain treatments failures in acute otitis media. Pediatr Drugs. 2009;11(4):243-249. (Systematic review)
  109. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19(11):1040-1045. (Prospective study; 109 patients)
  110. Saez-Llorens X, Rodriguez A, Arguedas A, et al. Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. Pediatr Infect Dis J. 2005;24(4):293-300. (Randomized multicenter comparative study; 413 patients)
  111. Sher L, Arguedas A, Husseman M, et al. Randomized, investigator- blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. Pediatr Infect Dis J. 2005;24(4):301-308. (Randomized multicenter comparative study; 354 patients)
  112. Noel GJ, Blumer JL, Pichichero ME, et al. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Pediatr Infect Dis J. 2008;27(6):483-489. (Randomized multicenter comparative study; 1305 patients)
  113. Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother. 2003;47(10):3179-3186. (Randomized double-blinded multicenter comparative study; 304 patients)
  114. Turik MA, Johns D Jr. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy. J Chemother. 1998;10(4):306-312. (Randomized comparative study; 205 patients)
  115. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for the treatment of acute otitis media. Pediatr Infect Dis J. 2001;20(3):260-264. (Prospective study; 54 patients)
  116. Bertin L, Pons G, d’Athis P, et al. A randomized, doubleblind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol. 1996;10(4):387-392. (Randomized double-blinded multicenter controlled trial; 219 patients)
  117. Perrott DA, Piira T, Goodenough B, et al. Efficacy and safety of acetaminophen vs. ibuprofen for treating children’s pain or fever. Arch Pediatr Adolesc Med. 2004:158(6);521-526. (Metaanalysis; 1820 patients)
  118. Hoberman A, Paradise JL, Reynolds EA, et al. Efficacy of Auralgan for treating ear pain in children with acute otitis media. Arch Pediatr Adolesc Med. 1997;151(7):675-678. (Randomized controlled trial; 54 patients)
  119. Bolt P, Barnett P, Babl FE, et al. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebocontrolled randomised tri. Arch Dis Child. 2008;93(1):40-44. (Randomized double-blind controlled trial; 63 patients)
  120. Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med. 2001;155(7):796-769. (Randomized comparative trial; 103 patients)
  121. Foxlee R, Johansson A, Wejfalk J, et al. Topical analgesia for acute otitis media. Cochrane Database Syst Rev. 2009;2: CD005657. (Systematic review; 391 patients)
  122. Coleman C, Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2011;3:CD001727. (Meta-analysis; 2695 patients)
  123. Chonmaitree T, Saeed K, Uchida T, et al. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003;143(3):377-385. (Randomized controlled trial; 179 patients)
  124. Harsten G, Prellner K, Heldrup J, et al. Treatment failure in acute otitis media: a clinical study of children during their first three years of life. Acta Otolaryngol. 1989;108(3-4):253-258. (Retrospective study; 113 patients)
  125. Rovers MM, Glasziou P, Appelman CL, et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet. 2006;368(9545):1429-1435. (Meta-analysis; 1643 patients)
  126. Sanders S, Glasziou PP, DelMar C, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2009;(2):1-43. (Systematic review)
  127. Scholz H, Noack R. Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. Eur J Clin Microbiol Infect Dis. 1998;17(7):470-478. (Randomized double-blind multicenter comparative trial; 302 patients)
  128. Arguedas A, Emparanza P, Schwartz RH, et al. A randomized, multicenter, double-blind, double dummy trial of single dose azithromycin versus high-dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J. 2005;24(2):153-161. (Randomized double-blind multicenter comparative trial; 313 patients)
  129. Morris PS, Gadil G, McCallum GB, et al. Single-dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial. Med J Aust. 2010;192(1):24-29. (Randomized double-blind comparative trial; 320 patients)
  130. Block SL, McCarty JM, Hedrick JA, et al. Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19(12 Suppl):S159-S165. (Randomized double-blind comparative trial; 384 patients)
  131. Block SL, Busman TA, Paris MM, et al. Comparison of fiveday cefdinir treatment with ten-day low dose amoxicillin/ clavulanate treatment for acute otitis media. Pediatr Infect Dis J. 2004;23(9):834-838. (Randomized double-blind comparative trial; 425 patients)
  132. Hedrick JA, Sher LD, Schwartz RH, et al. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media. Clin Ther. 2001;23(2):193-204. (Randomized comparative trial; 304 patients)
  133. Pessey JJ, Gehanno P, Thoroddsen E, et al. Short-course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/ clavulanate. Pediatr Infect Dis J. 1999;18(10):854-859. (Randomized multicenter comparative trial; 716 patients)
  134. Block SL, Cifaldi M, Gu Y, et al. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. Clin Ther. 2005;27(6):786-794. (Randomized multicenter comparative trial; 357 patients)
  135. Block SL, Kratzer J, Nemeth MA, et al. Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media. Pediatr Infect Dis J. 2000;19(12 Suppl):S147-S152. (Randomized multicenter comparative trial; 373 patients)
  136. Cohen R, Levy C, Boucherat M, et al. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19(5):458-463. (Randomized doubleblind multicenter comparative trial; 450 patients)
  137. Sanders S, Glasziou PP, Del Mar CB, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2004;1:CD000219. (Systematic review; 2928 patients)
  138. Bluestone CD. Clinical course, complications, and sequelae of acute otitis media. Pediatr Infect Dis J. 2000;19(5 Suppl):S37-S46. (Review article)
  139. Giebink GS. Risk of mastoiditis in typical otitis media not managed by antibiotics. Lancet. 1982;1(8263):111.
  140. Linder TE, Briner HR, Bischoff T. Prevention of acute mastoiditis: fact or fiction? Int J Pediatr Otorhinolaryngol. 2000;56(2):129-134. (Retrospective case study; 48 patients)
  141. Nadal D, Herrmann P, Baumann A, et al. Acute mastoiditis: clinical, microbiological, and therapeutic aspects. Eur J Pediatr. 1990;149(8):560-564. (Retrospective case study; 73 patients)
  142. Dhooge IJ, Albers FW, Van Cauwenberge PB. Intratemporal and intracranial complications of acute suppurative otitis media in children: renewed interest. Int J Pediatr Otorhinolaryngol. 1999;49(Suppl 1):S109-S114. (Review article)
  143. Luntz M, Brodsky A, Nusem S, et al. Acute mastoiditis—the antibacterial agent era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001;57(1):1-9 (Retrospective multicenter case series; 223 patients)
  144. Van Zuijlen DA, Schilder AG, Van Balen FA, et al. National differences in acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J. 2001;20(2):140-144. (Retrospective comparative epidemiological study)
  145. Thompson PL, Gilbert RE, Long PF, et al. Effects of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United Kingdom general practice research database. Pediatrics. 2009;123(2):424-430. (Retrospective cohort study; 854 patients)
  146. Wu JF, Jin Z, Yang JM, et al. Extracranial and intracranial complications of otitis media: 22-year clinical experience and analysis. Acta Otolaryngol. 2012;132(3):261-265. (Retrospective study; 285 patients with complications among 2346 inpatients)
  147. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics. 1993;91(1):23-30. (Randomized double-blind controlled trial; 233 children)
  148. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007;136(3):340-347. (Meta-analysis; 41,400 patients)
  149. Pichichero ME. Use of selected cephalosporins in penicillinallergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007;57(suppl 3):13S-18S. (Review article)
  150. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259-273. (Practice guideline)
  151. Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg. 2001;124(4):374-380. (Meta-analysis; 134 articles)
  152. Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg. 2005;133(4):585-595. (Prospective randomized multi-center clinical trial; 1309 isolates from 956 ears)
  153. Fliss DM, Dagan R, Meidan N, et al. Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol. 1992;101(10):866-869. (Prospective study; 128 patients)
  154. Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/ dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope. 2003;113(12):2116-2122. (Randomized single-blind multicenter trial; 201 patients)
  155. Abes G, Espallardo N, Tong M et al. A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media. ORL J Otorhinolaryngol Relat Spec. 2003;65(2):106-116. (Systematic review; 1484 adults and children)
  156. Roland PS, Kreisler LS, Reese B, et al. Topical ciprofloxacin/ dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2004;113(1 Pt 1):e40-e46. (Randomized observer-blinded multicenter trial; 599 patients)
  157. Schmelzle J, Birtwhistle RV, Tan AK. Acute otitis media in children with tympanostomy tubes. Can Fam Physician. 2008;54(8):35-42. (Review article)
  158. Daniel SJ, Kozak FK, Fabian MC, et al. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol. 2005;34(Suppl 2):S60-S63. (Clinical practice guidelines)
  159. Spigelblatt L, Laine-Ammara G, Pless IB, et al. The use of alternative medicine by children. Pediatrics. 1994;94(6 Pt 1):811-814. (Retrospective survey; 1911 patients)
  160. Jacobs J, Springer DA, Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis J. 2001;20(2):177- 183. (Randomized double-blind placebo-controlled trial; 75 patients)
  161. Mills MV, Henley CE, Barnes LL, et al. The use of osteopathic manipulative treatment as adjuvant therapy in children with recurrent acute otitis media. Arch Pediatr Adolesc Med. 2003;157(9):861-866. (Randomized controlled trial; 57 patients)
  162. Gaboury I, Coyle K, Coyle D, et al. Treatment cost-effectiveness in acute otitis media: a watch-and-wait approach versus amoxicillin. Paediatr Child Health. 2010;15(7):e14-e18. (Economic analysis of a randomized controlled trial; 488 patients)
Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Publication Information

Chadd E. Nesbit, Margaret C. Powers

Publication Date

April 1, 2013

Get Permission

Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Please provide a valid email address.